PF-04950615 (RN316)

PF-04950615 · Pfizer

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for PF-04950615 (RN316), covering 2012-07-04 to 2019-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia [Phase 1]